Table 1.

SPMs

SPM	N	Median time to SPM diagnosis, months (range)	ASCT	Gender	On study
Solid tumors (stage)	6	35 (8-71)
Metastatic melanoma	1	8 mo	No	M	On
Colon (IV)	1	25 mo	No	M	On
Colon (III)	1	31 mo	No	F	Off
Pancreas (II)	1	39 mo	Yes	M	Off
Prostate (II)	1	53 mo	No	M	On
Lung carcinoid (I)	1	71 mo	Yes	F	Off
Hematologic tumors	0
Basal cell carcinoma	4	42 (5-64)	No	2F, 2M	On
Squamous cell carcinoma	2	29.5 (28-33)	No	2M	On/Off

Invasive tumors were seen at a rate expected by SEER database. No hematologic malignancies were seen. No association noted with multiple variables analyzed.

F, female; M, male; SEER, Surveillance Epidemiology and End Results.